Status:
COMPLETED
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
Lead Sponsor:
University of Leipzig
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Acetylcystein is a potent antioxidans which is able to prevent contrast dye induced nephropathy in stable patients undergoing additional hydration. In primary percutaneous intervention for infarction...
Eligibility Criteria
Inclusion
- ST-elevation infarction (\<12 hours)
- Angina
Exclusion
- Prior fibrinolysis
- Dialysis
- Pregnancy
- Lactase-reduction
- Glucose-galactose malabsorption
- Known allergy to acetylcystein
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT00463749
Start Date
December 1 2006
End Date
June 1 2008
Last Update
July 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leipzig - Heart Center
Leipzig, Germany, 04289